Overview

A Clinical Trial to Evaluate Efficacy, Tolerability, and Pharmacokinetic-Pharmacodynamic Relationship of Fimasartan/Hydrochlorothiazide

Status:
Completed

Trial end date:
2015-06-01

Target enrollment:

Participant gender:

Summary

A 2-Week, Randomized, Double-Blind, Parallel, Placebo-Controlled Study to Evaluate the Efficacy, Tolerability, and Pharmacokinetic-Pharmacodynamic Relationship of Fimasartan in Combination with Hydrochlorothiazide in Patients with Mild to Moderate Hypertension

Phase:

Phase 2

Details

Lead Sponsor:

Boryung Pharmaceutical Co., Ltd

Collaborator:

Seoul National University Hospital

Treatments:

Hydrochlorothiazide